• Epalrestat and KEAP1/Nrf2 Neuroprotection in PD

  2026-09-14

  Jia et al. report that Epalrestat, an established aldose reductase inhibitor, protects dopaminergic neurons in cellular and mouse Parkinson’s disease models by reducing oxidative stress and mitochondrial dysfunction. The study’s central innovation is evidence that Epalrestat directly interacts with KEAP1, promoting Nrf2 pathway activation and supporting a preclinical repurposing rationale for neuroprotection.

• TRAP-1 and Mutant p53Y220C Reactivation

  2026-09-14

  The preprint identifies TRAP-1, a chemical inducer of proximity that brings mutant p53Y220C into a ternary complex with BRD4 and restores transcription of p53-responsive genes. Its matched control compounds and cellular experiments support chemically induced proximity as the key pharmacological mechanism, while the preprint status and mutation-specific models define important limits for interpretation.

• Agatoxin-Sensitive Calcium Channels in Vagal Neurons

  2026-09-13

  Wang, Irnaten, and Mendelowitz used whole-cell patch clamp recordings to show that agatoxin-IVA-sensitive voltage-dependent calcium channels link nicotinic receptor activation to both direct excitation and enhanced glutamatergic transmission in cardiac vagal neurons. The study distinguishes a P-type-sensitive mechanism shared by presynaptic and postsynaptic responses from an additional L-type contribution to synaptic facilitation.

• EDC.HCl: Practical Coupling Workflow Guide

  2026-09-12

  EDC.HCl is a water-soluble carbodiimide used to activate carboxyl groups for amide bond formation with primary amines in peptide synthesis, bioconjugation, and related in vitro workflows. It should be handled as a research reagent only; the product dossier reports no in vivo or clinical data, and freshly prepared solutions are preferred over long-term storage.

• Biotin-HPDP: Reversible Thiol Labeling

  2026-09-11

  A practical, scenario-driven guide to using Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide), SKU A8008, for reversible thiol-specific protein labeling and downstream streptavidin detection. It connects reagent chemistry with controls, solvent handling, affinity purification, S-nitrosylation workflows, and interpretation of cell-based assay results.

• Extracellular Vesicle ACLY Drives HCC TAMs

  2026-09-11

  The reference study identifies extracellular vesicle-transferred ATP-citrate lyase (ACLY) as a metabolic signal that directs monocytes toward immunosuppressive tumor-associated macrophages in hepatocellular carcinoma. Its engineered CD81-decorated vesicles provide a causal delivery model and suggest that TAM-specific ACLY inhibition may improve anti-PD-1/PD-L1 responses.

• L-Ornithine B8919 for Reliable Cell Assays

  2026-09-10

  A scenario-driven guide to using L-Ornithine (SKU B8919) in cell viability, proliferation, cytotoxicity, and amino acid metabolism research. It connects formulation, solubility, protocol controls, vendor evaluation, and recent liver–brain-axis evidence to improve experimental interpretability.

• c-Myc Tag Peptide: From Assay Control to Translation

  2026-09-10

  A mechanistic and strategic guide to using c-Myc Peptide as a defined competition reagent for immunoassays, while connecting c-Myc biology, transcription factor regulation, and translational assay design.

• EdU as a Translational Lens on CRC Metabolism

  2026-09-09

  The serine/glycine-free diet study reveals a translational paradox in colorectal cancer: metabolic restriction can enhance cytotoxic immunity while also stabilizing PD-L1 through lactylation. This article explains how EdU-based flow cytometry can separate tumor-cell DNA synthesis from immune-cell proliferation, strengthening pharmacodynamic and mechanistic studies built around that finding.

• Estradiol Benzoate: An Assay-Design Framework

  2026-09-09

  Estradiol Benzoate can do more than activate ERα: it can anchor a tiered strategy for separating receptor binding, transcriptional response, and formulation artifacts. This guide translates computational-screening lessons into more rigorous estrogen receptor signaling research.

• Dinaciclib Selectivity in VHL-Deficient Renal Cancer

  2026-09-08

  Nelson and colleagues identify a preclinical synthetic-lethal relationship between Dinaciclib treatment and VHL deficiency in clear cell renal cell carcinoma. Their combination of cell-based assays, pathway analysis, VHL re-expression, and an orthotopic patient-derived xenograft model supports selective targeting of both tumor cells and CD105-defined cancer stem-cell populations, while also highlighting important translational limitations.

• Purmorphamine: Smoothened Agonist Workflows

  2026-09-08

  Purmorphamine is a practical Smoothened agonist for connecting Hedgehog pathway activation with osteogenic, receptor-level, and sensory readouts. This guide translates product specifications and honeybee Smo findings into dose-aware workflows, controls, and troubleshooting strategies for bone regeneration research and beyond.

• Self-Assembling EVMPs for Extrahepatic mRNA Delivery

  2026-09-07

  Yu and colleagues developed a bottom-up enveloped virus-mimicking particle (EVMP) that combines a self-assembling virus-mimicking peptide with programmable phospholipid envelopes for extrahepatic mRNA delivery. The platform achieved substantial lung-cell transfection and produced antitumor activity when loaded with IL-12 mRNA, while its modular design addresses important limitations of viral vectors and conventional liver-biased nanoparticles.

• Pyridostigmine Targets Placental Necroptosis in PE

  2026-09-07

  The reference study identifies placental necroptosis as a pharmacologically tractable component of preeclampsia-like pathology in rats. Its experiments link pyridostigmine-enhanced non-neuronal cholinergic signaling to α7 nicotinic acetylcholine receptor activity, reduced inflammation and oxidative stress, and improved trophoblast behavior.

• Nullscript: Translational Logic for HDAC Inhibition

  2026-09-05

  Nullscript offers a useful way to separate HDAC inhibition from transcriptional facilitation in translational research. This article connects its cardiac ischemia/reperfusion evidence with the mechanistic discipline demonstrated by recent RIPK3-necroptosis research, while defining practical limits for cardiovascular, neurodegeneration, and oncology studies.

8115 records 1/541 page Next 12345 下5页 Last page